University of Pittsburgh School of Pharmacy Announces Research Funding and Achievements
PITTSBURGH, Nov. 8, 2010 – The University of Pittsburgh School of Pharmacy faculty and staff often are honored by prestigious organizations for their achievements and exceptional leadership. The following individuals are among those who recently have been recognized with research grants, awards and appointments.
- Kim Coley, Pharm.D., professor of pharmacy and therapeutics, and Patricia Kroboth, Ph.D., dean and professor of pharmaceutical sciences, received a $93,500 grant from the Jewish Healthcare Foundation to lead a one-year project to develop, implement and assess a model of care that incorporates a pharmacist advocate in the patient care transition team. This model will focus on empowering patients to more effectively manage their medications and health when discharged from the hospital, with the ultimate goal of reducing and preventing readmission to the hospital.
- Alexander Doemling, Ph.D., associate professor of pharmaceutical sciences, received a three-year, $1 million grant from the National Institutes of Health for his research “Protein-Protein Interaction Directed Libraries.” Protein interactions are involved in all disease relevant pathways and are important for the future design of drugs to address unmet medical needs, such as diabetes, cancer and Alzheimer’s disease. This effort will develop libraries of new, diverse and biologically inspired compounds that encourage or discourage interactions between proteins. The libraries will reveal novel biological patterns and lead to follow-up projects to better understand individual protein-protein interactions and their involvement in disease pathology.
- Robert Gibbs, Ph.D., professor of pharmaceutical sciences, received a three-year, $400,000 grant from the National Science Foundation to study the role of a cell membrane protein called GPR30 in estrogen-mediated effects on cholinergic function and cognition.
- Song Li, M.D., Ph.D., associate professor of pharmaceutical sciences, received a $114,000 grant from the U.S. Department of Defense for research to develop a nanotechnology-based targeted therapy for the treatment of breast cancer.
- Janice Pringle, Ph.D., research associate professor of pharmacy and therapeutics, served on the State Screening, Brief Intervention and Referral to Treatment (SBIRT): Systems Implementation, Implications and Impact Panel. The goal of SBIRT is to develop and implement training programs to teach medical residents the skills to provide evidence-based screening, intervention and referral to treatment for patients who have, or are at risk for, substance use disorders. The panel took place during the Substance Abuse and Mental Health Services Administration Innovation in Treatment and Recovery Systems Conference in Baltimore in August.
About the University of Pittsburgh School of Pharmacy
Chartered in 1878, the School of Pharmacy is the oldest of the University of Pittsburgh’s Schools of the Health Sciences. The school offers a four-year doctor of pharmacy degree (Pharm.D.) as well as a postgraduate residency program. A leader in research, the School of Pharmacy is nationally known for its Clinical Pharmaceutical Scientist Program, a Ph.D. program that educates scientists to conduct translational or patient-oriented research. The school also offers a pharmaceutical science Ph.D. program and a master’s degree in pharmacy administration. The school is home to the Center for Pharmacogenetics and the Center for Education and Drug Abuse Research (CEDAR) and is a partner in the three-school Drug Discovery Institute. The Grace Lamsam Pharmacy Program for the Underserved and the Pittsburgh Poison Center/Drug Information Center and the partnership with UPMC reflect the School’s quality and excellence at the intersection of patient care, education, research and service. For more information about the School of Pharmacy, visit www.pharmacy.pitt.edu.